Publication | Open Access
SPIO-loaded nanostructured lipid carriers as liver-targeted molecular T2-weighted MRI contrast agent
21
Citations
20
References
2018
Year
We successfully developed liver-targeting MNLCs, which showed accurate hepatocytes targeting, and thus have the potential to be a new MRI contrast agent to help the diagnosis of liver diseases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1